SCHEMBL2197255

SCHEMBL2197255

Cc1ccc2nc(-c3ccc(NC(=O)c4ccc(N(C)C)cc4)cc3)cn2c1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 13/20 0.69
KDM4E B2RXH2 4/20 0.65
NPC1 O15118 4/20 0.65
ALDH1A1 P00352 4/20 0.65
SMN1; SMN2 Q16637 4/20 0.65
RAB9A P51151 4/20 0.65
HPGD P15428 3/20 0.65
MEN1 O00255 2/20 0.54
KMT2A Q03164 2/20 0.54
CYP2C19 P33261 1/20 0.54
HTT P42858 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
MITF O75030 1/20 0.52
KDM5A P29375 1/20 0.52
KDM5C P41229 1/20 0.52
PAX8 Q06710 1/20 0.52
POLB P06746 1/20 0.52
MCHR1 Q99705 1/20 0.50
LMNA P02545 1/20 0.50
MAPT P10636 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16623339 0.91 NPC1 (0.74) APPKDM4ENPC1ALDH1A1SMN1; SMN2
SCHEMBL2195111 0.89 APP (0.70) APPKDM4ENPC1ALDH1A1SMN1; SMN2
SCHEMBL2194775 0.89 APP (0.70) APPKDM4ENPC1ALDH1A1SMN1; SMN2
SCHEMBL2194816 0.87 NPC1 (0.70) APPKDM4ENPC1ALDH1A1SMN1; SMN2
SCHEMBL2194530 0.87 NPC1 (0.70) APPKDM4ENPC1ALDH1A1SMN1; SMN2
SCHEMBL2193852 0.86 NPC1 (0.68) APPKDM4ENPC1ALDH1A1SMN1; SMN2
SCHEMBL1984261 0.86 SMN1; SMN2 (0.71) APPKDM4ENPC1ALDH1A1SMN1; SMN2
SCHEMBL12422026 0.86 KDM4E (0.74) KDM4ENPC1ALDH1A1SMN1; SMN2RAB9A
SCHEMBL12509330 0.85 NPC1 (0.67) APPKDM4ENPC1ALDH1A1SMN1; SMN2
SCHEMBL1995023 0.85 RAB9A (0.60) APPKDM4ENPC1ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2338059-B1 Ligands for aggregated tau molecules WISTA LAB LTD (SG) 2015-04-08 EP disclosed
EP-2338059-B1 Ligands for aggregated tau molecules WISTA LAB LTD (SG) 2015-04-08 EP disclosed
US-8895313-B2 Ligands for aggregated tau molecules WISTA LABORATORIES LTD. (SG) 2014-11-25 US disclosed
US-8895313-B2 Ligands for aggregated tau molecules WISTA LABORATORIES LTD. (SG) 2014-11-25 US disclosed
US-8895313-B2 Ligands for aggregated tau molecules WISTA LABORATORIES LTD. (SG) 2014-11-25 US disclosed
US-20110171739-A1 LIGANDS FOR AGGREGATED TAU MOLECULES WISTA LABORATORIES LTD. 2011-07-14 US disclosed
US-20110171739-A1 LIGANDS FOR AGGREGATED TAU MOLECULES WISTA LABORATORIES LTD. 2011-07-14 US disclosed
US-20110171739-A1 LIGANDS FOR AGGREGATED TAU MOLECULES WISTA LABORATORIES LTD. 2011-07-14 US disclosed
WO-2010034982-A1 LIGANDS FOR AGGREGATED TAU MOLECULES WISTA LABORATORIES LTD. (SG) 2010-04-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110171739-A1 LIGANDS FOR AGGREGATED TAU MOLECULES MAPT, PRNP, MAP4 APP 17/4885KDM4E 4073/4885NPC1 1265/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.